Abstract: A portable body cooling device, worn on the upper torso of a person, that uses a compressed or liquefied gas cartridge to vent cool gas onto the skin of the wearer as well as to act as a heat sink during the gas release. The cartridge is in contact with a conductive material that transfers heat from the skin of the wearer to the cartridge. The cooling device provides immediate and temporary relief from heat flashes.

Abstract: Described in this application for patent is a cover for treating the hoof or leg of a hooved animal. The cover includes a hoof shoe and a sock joined at a seam. The hoof shoe includes a pocket for receiving the hoof of the animal and provides a continuous outer surface for enclosing the hoof and a cushioned bottom portion allowing for treatment to the underside of the hoof. The sock includes a liner, such as silicone or thermoplastic polyurethane, which adheres to the skin or hair of the animal and prevents the cover from being displaced during wear.

Abstract: The present invention provides fusion proteins for the detection and treatment of neuroectodermal tumors. Previous work demonstrated that chlorotoxin is specific for glial-derived or meningioma-derived tumor cells. The current invention has extended the use of chlorotoxin-cytotoxin fusion proteins to treat the whole class neuroectodermal tumors such as gliomas, meningiomas, ependymonas, medulloblastomas, neuroblastomas, gangliomas, pheochromocytomas, melanomas, PPNET's, small cell carcinoma of the lung, Ewing's sarcoma, and metastatic tumors in the brain. Also, diagnostic methods are provided for screening neoplastic neuroectodermal tumors.

Abstract: The present invention provides fusion proteins for the detection and treatment of neuroectodermal tumors. Previous work demonstrated that chlorotoxin is specific for glial-derived or meningioma-derived tumor cells. The current invention has extended the use of chlorotoxin-cytotoxin fusion proteins to treat the whole class neuroectodermal tumors such as gliomas, meningiomas, ependymonas, medulloblastomas, neuroblastomas, gangliomas, pheochromocytomas, melanomas, PPNET's, small cell carcinoma of the lung, Ewing's sarcoma, and metastatic tumors in the brain. Also, diagnostic methods are provided for screening neoplastic neuroectodermal tumors.

Abstract: The present invention provides fusion proteins for the detection and treatment of neuroectodermal tumors. Previous work demonstrated that chlorotoxin is specific for glial-derived or meningioma-derived tumor cells. The current invention has extended the use of chlorotoxin-cytotoxin fusion proteins to treat the whole class neuroectodermal tumors such as gliomas, meningiomas, ependymonas, medulloblastomas, neuroblastomas, gangliomas, pheochromocytomas, melanomas, PPNET's, small cell carcinoma of the lung, Ewing's sarcoma, and metastatic tumors in the brain. Also, diagnostic methods are provided for screening neoplastic neuroectodermal tumors.

Abstract: A topical medicament, and associate method of use, for the treatment of dermatologic conditions in both humans and animals is provided. The medicament includes a mixture of Vitamin A, Vitamin D, Vitamin E, lanolin, petroleum jelly, colloidal silver, ti tree oil, zinc oxide and corn starch in appropriate proportions. Ingredient proportions may be varied to form an ointment or a paste having a thicker consistency than the ointment.

Abstract: A method of processing a communication apparatus includes putting the communication apparatus into a distribution channel for distribution via one or more intermediaries to a user of the communication apparatus, the user of which can forward the communication apparatus to a desired recipient. The communication apparatus includes a substrate and a communication element coupled to the substrate and is constructed of one or more materials that are a bio-technical nutrient. The communication apparatus is received from a recipient directly or via one or more intermediaries. The communication apparatus is processed to prepare a second communication apparatus for distribution to another user.

Abstract: The present invention provides fusion proteins for the detection and treatment of neuroectodermal tumors. Previous work demonstrated that chlorotoxin is specific for glial-derived or meningioma-derived tumor cells. The current invention has extended the use of chlorotoxin-cytotoxin fusion proteins to treat the whole class neuroectodermal tumors such as gliomas, meningiomas, ependymonas, medulloblastomas, neuroblastomas, gangliomas, pheochromocytomas, melanomas, PPNET's, small cell carcinoma of the lung, Ewing's sarcoma, and metastatic tumors in the brain. Also, diagnostic methods are provided for screening neoplastic neuroectodermal tumors.

Abstract: The present invention provides fusion proteins for the detection and treatment of neuroectodermal tumors. Previous work demonstrated that chlorotoxin is specific for glial-derived or meningioma-derived tumor cells. The current invention has extended the use of chlorotoxin-cytotoxin fusion proteins to treat the whole class neuroectodermal tumors such as gliomas, meningiomas, ependymonas, medulloblastomas, neuroblastomas, gangliomas, pheochromocytomas, melanomas, PPNET's, small cell carcinoma of the lung, Ewing's sarcoma, and metastatic tumors in the brain. Also, diagnostic methods are provided for screening neoplastic neuroectodermal tumors.

Abstract: The present invention provides fusion proteins for the detection and treatment of neuroectodermal tumors. Previous work demonstrated that chlorotoxin is specific for glial-derived or meningioma-derived tumor cells. The current invention has extended the use of chlorotoxin-cytotoxin fusion proteins to treat the whole class neuroectodermal tumors such as gliomas, meningiomas, ependymonas, medulloblastomas, neuroblastomas, gangliomas, pheochromocytomas, melanomas, PPNET's, small cell carcinoma of the lung, Ewing's sarcoma, and metastatic tumors in the brain. Also, diagnostic methods are provided for screening neoplastic neuroectodermal tumors.

Abstract: A compliant tower is disclosed having a foundation connected to a wide-bodied compliant framework with a plurality of vertically extending legs a minimum of horizontal bracing. The compliant framework is configured to maintain a substantially wide, open riser suspension corridor. A topside facility is supported by the compliant framework and a plurality of freely suspended production risers extend through the riser suspension corridor from the vicinity of the topside facility to communicate with the reservoir. These production risers are spaced to provide clearance to prevent riser interference in response to normal flexure of the compliant tower and normal environmental loads on the risers. A riser support assembly is configured to accomodate relative motion between the risers and the topside facility, supporting the production risers in tension near their upper ends to provide the principal load transfer between the riser and the compliant framework.